InsidersTradesSigma
티움바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 티움바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 티움바이오 has recorded 13 reports. The latest transaction was reported on 22 April 2022 (Sale). Among the most active insiders: 김훈택. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 April 2022
Declarations13 total
2,574,623 sharesKRXDART:20220422000656
2,574,623 sharesKRXDART:20211224000476
2,574,623 sharesKRXDART:20211130002070
2,574,623 sharesKRXDART:20210402000323
13 of 13 declarations
About 티움바이오
Tium Bio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.